OCTAGON RESEARCH SOLUTIONS APPOINTS ARTHUR CAPLAN AND GEORGE CHU TO ADVISORY BOARD
KING OF PRUSSIA, PA - September 10, 2003 - Octagon Research Solutions, a leading provider of regulatory, clinical information management, process and information technology products and services to the life sciences industry, announced today that the Company has appointed Arthur Leonard Caplan, Ph.D. and George S. Chu, Ph.D. to its Advisory Board.
Dr. Caplan is a prominent medical ethicist and scientist who specializes in identifying ways to improve the researchprocess,while Dr. Chu brings expertise in operations and finance vital for a growing company.
"Octagon’s process management software solutions and strategic approach to the clinical research and development process demonstratesa deep understanding of what it takes to speed the electronic submission process,” said Dr. Caplan. "The Company’s industry expertise and innovative software solutions are outstanding.”
Dr. Caplan holds various positions at the University of Pennsylvania School of Medicine, including the Emmanuel and Robert Hart Professor of Bioethics, Chair of the Department of Medical Ethics and the Director of the Center for Bioethics. He is the author or editor of 25 books and over 500 papers in journals of medicine, science, philosophy, bioethics and health policy as well as a regular columnist for MSNBC.com.
Dr. Caplan has served on numerous international and national committees including the Chair of the Advisory Committee to the United Nations on Human Cloning and the Chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability. Caplan received a Ph.D. in the history and philosophy of science from Columbia University.
George S. Chu, Ph.D., executive vice president for The Kinnamon Group, a firm that provides consulting/outsourcing services to public and private sector clients, has more than 25 years of experience in healthcare mergers/acquisitions, healthcare corporate finance and healthcare operations.
"Octagon has a remarkable record of profitability and a wide client base for a young company,” Chu noted. "I am confident that my experience in strategic planning and finance will help the Company achieve the next level of success.”
Dr. Chu began his career in healthcare by directing the inpatient clinical operations of the world-renowned Philadelphia Child Guidance Clinic, a pioneer in the psychiatric treatment of children and their families. He has been an advisor to healthcare corporations in strategic planning and corporate finance as well as provided consulting and interim management services to various corporations such as Alvarez & Marsal and Linc Financial Services.
Dr. Chu received a Ph.D. in clinical psychology from Adelphi University and an M.B.A. from The Wharton School of Finance at the University of Pennsylvania.
"Both Dr. Caplan and Dr. Chu are pre-eminent leaders in their respective fields,” said James C. Walker, President and CEO of Octagon Research Solutions. "Their appointment to our Advisory Board demonstrates that Octagon is bringing together the top visionaries in our field and is another important endorsement of our business strategy and software products.”
About Octagon Research Solutions, Inc.
Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and creative use of technology. Octagon is headquartered in King of Prussia, PA, with an office in Boston, MA. For more information please visit www.octagonresearch.com.
|
